R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Associate Director - Project Management, Patient Support Program Operations

Program ManagementConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 8 years of experience in patient services, hub operations, healthcare operations, specialty pharmacy, market access, or a related field.
  • At least 3 years of project management experience.
  • Experience supporting cross-functional healthcare programs, documentation governance, and operational processes.
  • Experience managing vendor relationships and coordinating service provider deliverables.

Responsibilities

  • Lead hub-related launches, service enhancements, operational improvements, and transitions, with accountability for integrated plans, cross-functional delivery, and operational outcomes.
  • Set execution priorities, resolve dependencies, and manage risks and changes within approved scope, policies, and budgets; escalate decisions affecting strategy, funding, policy, or contractual commitments to the Director.
  • Own the lifecycle of program documentation and patient support materials, including business requirements documents, standard operating procedures, workflows, training resources, enrollment forms, patient and provider communications, consent documents, and program templates.
  • Establish documentation standards, ownership, review schedules, version control, retention, and distribution processes; ensure internal teams and vendors use current approved materials.
  • Own reporting requirements, metric definitions, data validation, and delivery of reports and dashboards that provide actionable visibility into patient access, service delivery, and vendor performance.
  • Translate findings into prioritized operational improvements and leadership recommendations; implement changes within established authority and escalate those requiring additional resources or strategic decisions.
  • Lead internal and vendor governance forums to drive decisions, resolve barriers, and hold stakeholders accountable for commitments; maintain clear decision records, action owners, and escalation pathways.
  • Own the Review Committee submission and review process, including priorities, timelines, approval records, and audit trails; ensure required approvals and operational updates are completed before implementation.
  • Oversee hub vendor and service provider performance against agreed deliverables, service levels, and quality standards; require corrective actions and verify resolution of performance gaps.
  • Lead vendor onboarding, implementation readiness, and contingency planning; assess readiness against defined criteria and recommend launch approval to the Director, identifying unresolved risks and required exceptions.
  • Define operational requirements for statements of work and vendor changes, oversee budget tracking and invoice validation, and resolve discrepancies within established authority; escalate material variances and funding needs to the Director.
  • Lead operational audit preparation, quality reviews, and remediation; maintain effective change controls and ensure adherence to company requirements for confidential information and patient data.

Desired Qualifications

  • A master's degree in business administration, healthcare administration, public health, or a related field is preferred.
  • A Project Management Professional (PMP), Certified Associate in Project Management (CAPM), or comparable project management certification is preferred.
  • Launch and customer-facing experience is preferred.
  • Oral oncology product experience is strongly preferred.
  • Experience in a smaller, rapidly growing company is preferred.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs